# Bright Minds' shares soar on positive Phase 2 seizure reduction data

**Source:** Endpoints News
**URL:** https://e.endpointsnews.com/t/t-l-wpiudl-jykykhhuld-u/
**Date:** 2026-01-07

---

Ian McDonald, Bright Minds Biosciences CEO

January 6, 2026 11:33 AM EST R&D

Ayisha Sharma

News Reporter

Bright Minds Bio­sciences said its se­lec­tive sero­tonin re­cep­tor ag­o­nist suc­ceed­ed in a mid-stage tri­al for two dif­fer­ent types of seizures, and it plans to take …

---

#news #endpoints-news
